Rankings
▼
Calendar
ANIK Q2 2022 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$213M
Q2 2022 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$40M
+4.0% YoY
Gross Profit
$25M
62.7% margin
Operating Income
-$3M
-8.5% margin
Net Income
-$3M
-7.2% margin
EPS (Diluted)
$-0.20
QoQ Revenue Growth
+8.1%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
$1M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$354M
Total Liabilities
$68M
Stockholders' Equity
$286M
Cash & Equivalents
$91M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$40M
$38M
+4.0%
Gross Profit
$25M
$21M
+19.5%
Operating Income
-$3M
$9M
-136.8%
Net Income
-$3M
$7M
-143.5%
Revenue Segments
OA Pain Management
$26M
65%
Joint Preservation and Restoration
$12M
30%
Non-Orthopedic
$2M
5%
Geographic Segments
UNITED STATES
$30M
85%
Europe
$5M
15%
← FY 2022
All Quarters
Q3 2022 →